research study durations This is one of the most important differences to understand
In a 2024 joint court filing, the two companies said that the safety profile of GLP-1 RAs has been well-established in hundreds of clinical trials, large-scale observational studies, and nearly two decades of real-world use
Starting at a low dose and escalating slowly is one of the most effective ways to improve tolerability. Diarrhea Diarrhea is more common during dose escalation periods when the body is adapting to a higher amount of medication
It also protects the skin from oxidative stress, boosts skin health, and promotes a clearer complexion
Were also seeing that theres already sleep challenges
The most frequently reported symptoms included: Nausea (the most common, with rates varying by dose readers should refer to the published trial data and supplementary tables for dose-specific figures) Vomiting Diarrhoea Constipation Upper abdominal pain or discomfort Decreased appetite These effects are largely attributable to the drug's action on GLP-1 receptors in the gastrointestinal tract, which slow gastric motility and alter gut hormone signalling